Business · 03/08/2006

FDA Amends Animal Drug Regulations to Simplify Kanamycin, Bismuth Subcarbonate, and Activated Attapulgite Specifications

The US Food and Drug Administration (FDA) is updating its animal drug regulations to remove inactive ingredients from the specifications for oral suspensions and tablets containing kanamycin, bismuth subcarbonate, and activated attapulgite, aiming to enhance the accuracy and clarity of the regulations.